what is peptide ss31 SS-31 is reported to protect against mitochondrial dysfunction - SS31 peptideside effects is a small peptide What is Peptide SS-31? Understanding its Role in Mitochondrial Health and Aging

SS-31peptidedosage Peptide SS-31, also known as elamipretide, is a groundbreaking synthetic tetrapeptide designed to target and protect mitochondria, the crucial energy-producing powerhouses within our cells作者：Y Zhu·2022·被引用次数：57—SS-31, a mitochondria-targeting antioxidant, has received significant research attention as it decreases mitochondrial reactive oxygen species production.. This mitochondria-penetrating peptide has garnered significant attention for its potent antioxidant properties and its ability to improve cellular energy production, making it a subject of intense research in areas ranging from anti-aging to the treatment of various age-related diseases. SS-31's unique mechanism of action involves accumulating in mitochondria and directly interacting with cardiolipin on the inner mitochondrial membrane, thereby stabilizing energy output and reducing oxidative stressSS-31 (also known as Bendavia, Elamipretide, and MTP-131) isa small peptide that accumulates in mitochondria and scavenges reactive oxygen species..

The primary function of SS-31 revolves around its ability to enhance mitochondrial function. Mitochondria are susceptible to damage from reactive oxygen species (ROS), leading to oxidative stress and cellular dysfunction, which are hallmarks of aging and numerous pathological conditions. SS-31 acts as a potent scavenger of these harmful ROS, effectively mitigating oxidative damage within the mitochondriaImproving mitochondrial function with SS-31 reverses age .... This protective effect not only preserves mitochondrial integrity but also supports improved cellular energetics and overall physiological function.2025年5月9日—SS-31 is a mitochondria-targeted peptidethat supports energy, cellular repair, and anti-aging. Learn about its benefits and how to use it. Research indicates that SS-31 can ameliorate age-related mitochondrial dysfunction, leading to improvements in skeletal muscle energetics and exercise performance, as well as offering potential benefits in cognitive and physiological aging processes.SS-31 (also known as Bendavia, Elamipretide, and MTP-131) isa small peptide that accumulates in mitochondria and scavenges reactive oxygen species.

The Science Behind SS-31's Mitochondrial Targeting

The efficacy of SS-31 stems from its specific targeting of mitochondria. Unlike many other compounds, SS-31 is designed to penetrate cell membranes and preferentially accumulate within the mitochondria, particularly at the inner mitochondrial membrane. Here, it binds to cardiolipin, a phospholipid essential for the structure and function of mitochondrial respiratory complexes.The mitochondrial-targeted peptide, SS-31, improves ... This interaction is key to SS-31's ability to modulate mitochondrial membrane potential, enhance electron transport chain efficiency, and reduce the production of damaging free radicals.Performance Medical Clinic - Education This targeted approach ensures that its therapeutic effects are concentrated where they are most needed, minimizing off-target effects.作者：W Mitchell·2020·被引用次数：124—The mitochondria-targeted peptide SS-31binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action.

The Szeto-Schiller peptide SS31, as it is also known, has demonstrated remarkable potential in preclinical studies across a range of conditions. Its ability to scavenge mitochondrial ROS has been highlighted in research related to kidney protection, where it has been shown to guard against oxidative stress, inflammation, and apoptosis.SS-31 (also known as Bendavia, Elamipretide, and MTP-131)is a small peptide(D-Arg- dimethyl-Tyr-Lys-Phe-NH2) that accumulates in mitochondria and ... Furthermore, studies suggest SS-31 may play a role in neuroprotection, with research indicating its potential to reduce amyloid-beta production and improve mitochondrial dynamics in models relevant to Alzheimer's diseaseThe mitochondrial-targeted peptide, SS-31, improves .... Beyond these specific applications, SS-31 is being investigated for its broader role in ameliorating whole-body aging and improving cellular repair mechanisms.

Potential Applications and Research Directions

The therapeutic potential of SS-31 is vast, with ongoing research exploring its benefits in various fields作者：W Mitchell·2020·被引用次数：124—The mitochondria-targeted peptide SS-31binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action.. Its capacity to enhance cellular energy and combat oxidative stress makes it a promising candidate for addressing a spectrum of age-related changesA Novel Cell-permeable Antioxidant Peptide, SS31 .... Clinical studies have begun to support its use in managing conditions associated with aging, including those impacting cognition and overall physiology. The development of SS-31, or elamipretide, as a novel therapeutic approach addresses fundamental cellular energetic dysfunction, opening new avenues for treating chronic diseases and promoting healthier aging.作者：W Mitchell·2020·被引用次数：124—The mitochondria-targeted peptide SS-31binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action.

While SS-31 holds significant promise, it is important to note that much of the current understanding is derived from preclinical research and early-stage clinical trials2025年10月21日—SS-31(Elamipretide) is a mitochondria-targetedpeptidedesigned to improve energy production and reduce oxidative stress. Researchers have .... The peptide has been explored for its effects on conditions such as heart disease, where it has shown beneficial effects on cardiac mitochondrial dysfunction, and kidney disease, where it offers protection against oxidative damage. Its potential to improve mitochondrial function and reverse age-related decline in various tissues makes it a compelling subject for continued investigation. As research progresses, further insights into optimal dosages, potential side effects, and long-term efficacy will undoubtedly emerge, guiding its future clinical application. The peptide's ability to cross the blood-brain barrier also suggests potential for neurological applications, further expanding its therapeutic scope.